Harold Kroto Contemplates Applications of Nobel-Winning Fullerenes

Editor's Note: Last month, Sir Harold Kroto, the Royal Society Research Professor at the University of Sussex in Brighton, U.K., along with Richard E. Smalley, the Hackerman Professor of Chemistry at Rice University and Robert F. Curl, Jr., also a professor of chemistry at Rice, received the Nobel Prize in chemistry in Stockholm. They were honored for their discovery of buckyballs, the now-famous soccer-ball-shaped molecules named for architect R. Buckminster Fuller and his geodesic domes. The

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Editor's Note: Last month, Sir Harold Kroto, the Royal Society Research Professor at the University of Sussex in Brighton, U.K., along with Richard E. Smalley, the Hackerman Professor of Chemistry at Rice University and Robert F. Curl, Jr., also a professor of chemistry at Rice, received the Nobel Prize in chemistry in Stockholm. They were honored for their discovery of buckyballs, the now-famous soccer-ball-shaped molecules named for architect R. Buckminster Fuller and his geodesic domes. The 60-carbon-atom molecules are also called fullerenes. Since the discovery of C60 almost 12 years ago, "buckyballs" have captured the imagination of scientists and the public alike. At first the existence of buckyballs drew much skepticism, but over the last decade they have grown into a flourishing area of research. Few stories in the annals of contemporary science provide a stronger argument for pursuing fundamental research than the discovery of C60. In the early 1970s, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies